Asma e COVID-19: Atualização

Carvalho, Joana; Coutinho, Iolanda Alen; Nunes, Isabel; Moura, Ana Maria Marinho Andrade de; Regateiro, Frederico S.

doi:10.32932/rpia.2020.06.034

Cited by 5 publications

(4 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Because it is a disease that directly affects the airways, the idea arises that its presence may be related to susceptibility to infection and possibly exacerbations. However, according to Carvalho, et al, 2020, the relationship of asthma and COVID-19 is not yet very clear and does not seem to cause asthma exacerbations, nor have some characteristic signs of asthma, such as wheezing, been described in studies on COVID-19. According to the authors, the susceptibility and risk of severe COVID-19 among asthma patients may differ depending on age, disease severity, degree of control, their phenotype or endotype, or the type of treatment implemented 11 .…”

Section: Discussionmentioning

confidence: 99%

Hospitalization for COVID-19 in the municipality of Canoas/RS: Delineation of the population profile

Camargo¹,

Gasparetto²,

Dall’Ago³

et al. 2023

Connecting Expertise Multidisciplinary Development for the Future

View full text Add to dashboard Cite

Introduction: The COVID-19 pandemic started in March 2020 and is marked by a high number of infected. The symptoms of the disease are variable and the most severe cases occurred mainly in elderly patients and those with previous comorbidities. Objectives: To profile infected patients in the city of Canoas/RS, who required hospitalization for COVID-19; whose hospital discharge happened in January 2021. Method: This is a descriptive, exploratory, retrospective and documentary study, with a quantitative approach, where 51 medical records of patients living in Canoas/RS were analyzed, and had the hospital discharge in January 2021 with a positive diagnosis for the COVID-19 virus, at the city´s benchmark hospital. Results: The profile that was found: male, with an average age of 55,6 years old, white and single. The average hospitalization was 6,8 days. About the medications, the most frequently used was dexamethasone and, among other care prescribed after hospital discharge, the most known was the follow-up at the Basic Health Unit. Approximately 34 patients had some comorbidity and, also, more than half had previously used continuous medications. Only three patients in the study responded affirmatively about exposure to COVID-19 and the main symptoms presented by patients in general were dyspnea, cough and fever. Final considerations: The study shows that patients with advanced age and with chronic diseases are at greater risk of developing the severe form of COVID-19. The high rate of transmissibility can be observed by the absence of information regarding the natural history of the disease.

show abstract

Section: Discussionmentioning

confidence: 99%

Hospitalization for COVID-19 in the municipality of Canoas/RS: Delineation of the population profile

Camargo¹,

Gasparetto²,

Dall’Ago³

et al. 2023

Connecting Expertise Multidisciplinary Development for the Future

View full text Add to dashboard Cite

show abstract

“…Não se sabe ao certo se a asma é ou não um fator de risco para a COVID-19, porém, é certo que o controle insuficiente da asma predispõe à maior gravidade e exacerbação induzida por vírus. Assim, o controle ideal da asma reduzirá, inevitavelmente, o risco de desfechos graves nessa doença (Skevaki et al, 2020;Carvalho et al, 2020).…”

Section: Relação Das Alergias Respiratórias Com O Sars-cov-2unclassified

Imunidade e COVID-19: explorando fundamentos e perspectivas

2024

View full text Add to dashboard Cite

O ebook “Imunidade e COVID-19: Explorando Fundamentos e Perspectivas“, abrange uma ampla gama de tópicos relacionados à COVID-19. Da resposta inicial do corpo ao novo coronavírus até as implicações surpreendentes na saúde mental, esta obra da Liga de Imunologia e Doenças Autoimunes da Unimontes, mergulha nas nuances da COVID-19, explorando intrigantes conexões entre o vírus e autoimunidade, alergias respiratórias, estado nutricional e até mesmo a atividade física como um escudo protetor. Uma leitura importante para compreender a interação entre o sistema imune e a pandemia.

show abstract

“…y 2,4 más probabilidad de tener enfermedad grave en comparación con los no fumadores. 10 El asma bronquial es una enfermedad heterogénea, usualmente caracterizada por inflamación crónica de la vía aérea. Es definida por la historia de síntomas respiratorios tales como sibilantes, dificultad para respirar, opresión torácica y tos, que varía con el tiempo, intensidad, asociado a una limitación variable del flujo espiratorio.…”

Section: Introductionunclassified

COVID-19 en pacientes con asma bronquial en Clínica Internacional 2020-2021. Serie de casos

Sánchez-Vallejos,

Córdova-Sánchez,

Cabrera-Riveros

et al. 2024

Interciencia méd.

View full text Add to dashboard Cite

Introducción: La confluencia del asma, una enfermedad respiratoria crónica importante y prevalente, en ocasiones inhabilitante, asociada a COVID-19, la peor de las patologías recientes, de presentación global y aguda, ha generadosituaciones clínicas aún no bien establecidas, reportándose amplia variabilidad desde asintomáticos hasta insuficiencia respiratoria aguda y muerte. Ante la interrogante si el asma representa un factor de riesgo para la severidad de la COVID-19 en nuestra realidad, se obtuvo información en nuestra institución. Objetivo: Describir características clínicas y epidemiológicas de la COVID-19 en una serie de casos de pacientes con asma en Clínica Internacional en 2020-2021.Metodología: Investigación observacional, descriptiva, retrospectiva, de 55 casos con asma atendidos regularmente en consultorio con COVID-19 confirmado. Los datos se obtuvieron bajo encuesta y revisión de la historia clínica y se analizaron mediante SPSS.25, con nivel de significancia del 95%. Resultados: El 60% fueron mujeres y una mediana de 44 años; 72,7 % tuvieron sobrepeso u obesidad y 34,5% presentaron exacerbación asmática; 83,6 % presentó COVID-19 con severidad leve, 9,1 % moderado y 7,3 % severo; reportándose neumonía en 69,1% de los cuales se hospitalizaron el 52,9 %. El 78,2% cursaron con asma bien controlada y COVID-19 leve (p=0.317) El 49,1% con COVID-19 leve tenían asma intermitente o persistente leve (p=0.515). Se encontró asociación entre el IMC y la severidad del COVID-19 (p=0.028). Conclusiones: No se encontró asociación entre la severidad de la Covid-19 y el nivel de control y/o severidad del asma; más sí existió con el IMC, en la población estudiada.

show abstract

Asma e COVID-19: Atualização

Cited by 5 publications

References 23 publications

Hospitalization for COVID-19 in the municipality of Canoas/RS: Delineation of the population profile

Hospitalization for COVID-19 in the municipality of Canoas/RS: Delineation of the population profile

Imunidade e COVID-19: explorando fundamentos e perspectivas

COVID-19 en pacientes con asma bronquial en Clínica Internacional 2020-2021. Serie de casos

Contact Info

Product

Resources

About